New medical treatment modalities for castration resistant prostate cancer(CRPC), including hormonal therapy and chemotherapy, will be approved in Japan.
Here, we discuss the management of these new treatment strategies by urologists.
Ozono S. Are you the author?
Dept. of Urology, Hamamatsu University School of Medicine.
Reference: Gan To Kagaku Ryoho. 2014 Jul;41(7):823-6.
Article in Japanese.